Apr 19, 2021 (Market Insight Reports) -- Global Coagulation Analyzers Market Predicted to Accumulate over US$ 13.17 Billion by 2025 – Coherent Market Insights
The global coagulation analyzers market, by product type (Analyzers (Clinical Laboratory Analyzers, Point of Care Analyzers) and Consumables (Reagents & Kits, Point-of-care strips), by test type (Activated Partial Thromboplastin Time Test, Prothrombin Time Test, D-Dimer Test, Fibrinogen Test, and Other Coagulation Tests), and by end user (Hospitals, Diagnostic Laboratories, Research Institutes, and Others), was evaluated at US$ 2,481.78 million in 2017 and is now projected to demonstrate a CAGR of 9.7% during the forecast period (2017-2025).
Coagulation analyzers find extensive application in the diagnosis of bleeding disorders and thrombotic cases. These days, coagulation analyzers feature a fully automated infuse with several advanced features to perform various functions, such as cap piercing, primary tube sampling, dilution, and automatic rerun. These factors help reduce the total cost of the procedure, enhance the patient care quality, and assures regulatory compliance in the clinical laboratory. For instance, Instrumentation Laboratory, which is a product of Werfen Company, is designed for mid-to-high-volume clinical laboratories. The product offers the most advanced automation and quality management for routine, as well as specialty assays, including clotting, chromogenic, and immunological assays.
Request PDF Brochure Of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1255
The key market players are deeply engaged in the development of next-generation diagnostic analyzers to help to improve specificity, accuracy, and productivity of these procedures. These innovative analyzers are known to offer extraordinary results in lesser turnaround time, which makes them highly feasible for the operators. For instance, in July 2017, Sysmex America, Inc. launched its XN-L automated hematology analyzers in the U.S. to meet the demand of lower-volume hematology analyzers. In 2014, Xprecia Stride Coagulation Analyzer, a product by Siemens Healthineers, received the U.S. FDA approval for reliable monitoring of oral anticoagulation therapy with warfarin, a vitamin K antagonist. Furthermore, in 2015, the product received the Red Dot award for its design quality. Therefore, such factors augment the growth of the global coagulation analyzers market.
Manufacturers are also implementing strategic acquisitions and collaborations to extend their product portfolios, besides launching new platform technologies. For instance, in January 2012, Roche entered into a strategic alliance with Technoclone to expand its reagent portfolio in coagulation diagnostics. This helped Roche strengthen its foothold in the field of in-vitro diagnostics. Furthermore, in August 2015, Abbott Laboratories entered into a definitive agreement to acquire Omnilab in a bid to expand its lab offerings to the international markets outside the U.S.
Key Takeaways of the Global Coagulation Analyzers Market:
Among the various product types, the clinical laboratory analyzers segment is expected to spearhead the global coagulation analyzers market over the projected period, primarily due to the burgeoning use of these devices in hospitals for the hematological analysis of patients.
The prothrombin test segment accounted for the largest market fragment in 2016, owing to the increasing incidence of cardiovascular and blood related diseases worldwide. According to the Centers for Disease Control & Prevention (CDC), around 790,000 people in the U.S. suffer from heart attack annually, which indicates a potential need for immediate diagnosis and timely treatment in the country.
The most prominent players operating in the global coagulation analyzers market are Siemens AG, Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Instrumentation Laboratory, Sysmex Corporation, Beckman Coulter, Inc. (Danaher), Diamond Diagnostics, International Technidyne Corporation, Nihon Kohden Corporation, and Alere Inc.
To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/1255
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.